{"entity":{"type":"insider","cik":"0001350416","url":"/insider/0001350416","json_url":"/insider/0001350416.json","name":"Kaye Randall","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":17,"first":"2006-05-26","last":"2024-10-16","span_basis":"filed_date"},"name_variants":[{"name":"Kaye Randall","source":"filing","n_filings":17,"first_seen":"2006-05-26","last_seen":"2024-10-16"}],"transactions":[{"id":2039720,"accession":"0000950170-24-115026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-115026","line_url":"/filing/0000950170-24-115026#line-2","is_derivative":false,"issuer_cik":"0001350416","issuer_name":"Longboard Pharmaceuticals, Inc.","issuer_ticker":"LBPH","issuer_name_source":null,"issuer_url":"/issuer/0001350416","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":59.035,"price_display":"59.04","price_state":"stated","total_value":983936.345,"total_display":"983,936.34","total_whole":"983,936","shares_owned_after":17920.0,"shares_owned_after_display":"17,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-16","scope":"insider"},{"id":3021885,"accession":"0000950170-24-106949","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-106949","line_url":"/filing/0000950170-24-106949","is_derivative":false,"issuer_cik":"0001350416","issuer_name":"Longboard Pharmaceuticals, Inc.","issuer_ticker":"LBPH","issuer_name_source":null,"issuer_url":"/issuer/0001350416","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16666.0,"shares_display":"16,666","price_per_share":31.64035557422297,"price_display":"31.64","price_state":"stated","total_value":527318.166,"total_display":"527,318.17","total_whole":"527,318","shares_owned_after":25220.0,"shares_owned_after_display":"25,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-16","scope":"insider","n_lines":4},{"id":3075159,"accession":"0000950170-24-096496","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-096496","line_url":"/filing/0000950170-24-096496","is_derivative":false,"issuer_cik":"0001350416","issuer_name":"Longboard Pharmaceuticals, Inc.","issuer_ticker":"LBPH","issuer_name_source":null,"issuer_url":"/issuer/0001350416","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":34.72756860262795,"price_display":"34.73","price_state":"stated","total_value":578804.3859,"total_display":"578,804.39","total_whole":"578,804","shares_owned_after":24111.0,"shares_owned_after_display":"24,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider","n_lines":2},{"id":3075146,"accession":"0000950170-24-096496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-096496","line_url":"/filing/0000950170-24-096496#line-2","is_derivative":false,"issuer_cik":"0001350416","issuer_name":"Longboard Pharmaceuticals, Inc.","issuer_ticker":"LBPH","issuer_name_source":null,"issuer_url":"/issuer/0001350416","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.87,"price_display":"20.87","price_state":"stated","total_value":2087.0,"total_display":"2,087.00","total_whole":"2,087","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-25","filed_date":"2024-08-13","scope":"insider"},{"id":3075138,"accession":"0000950170-24-096496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-096496","line_url":"/filing/0000950170-24-096496#line-1","is_derivative":false,"issuer_cik":"0001350416","issuer_name":"Longboard Pharmaceuticals, Inc.","issuer_ticker":"LBPH","issuer_name_source":null,"issuer_url":"/issuer/0001350416","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":24.82,"price_display":"24.82","price_state":"stated","total_value":2482.0,"total_display":"2,482.00","total_whole":"2,482","shares_owned_after":100.0,"shares_owned_after_display":"100","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-08-13","scope":"insider"},{"id":8519125,"accession":"0001104659-15-086780","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-086780","line_url":"/filing/0001104659-15-086780#line-1","is_derivative":false,"issuer_cik":"0001350416","issuer_name":"Axsome Therapeutics, Inc.","issuer_ticker":"AXSM","issuer_name_source":null,"issuer_url":"/issuer/0001350416","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.026,"price_display":"9.03","price_state":"stated","total_value":9026.0,"total_display":"9,026.00","total_whole":"9,026","shares_owned_after":6022.0,"shares_owned_after_display":"6,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-23","filed_date":"2015-12-24","scope":"insider"},{"id":8997899,"accession":"0001209191-11-047733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-047733","line_url":"/filing/0001209191-11-047733#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":275000.0,"total_display":"275,000.00","total_whole":"275,000","shares_owned_after":65690.0,"shares_owned_after_display":"65,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-09","filed_date":"2011-09-13","scope":"insider"},{"id":9094871,"accession":"0001209191-11-002497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-002497","line_url":"/filing/0001209191-11-002497#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":40500.0,"total_display":"40,500.00","total_whole":"40,500","shares_owned_after":165690.0,"shares_owned_after_display":"165,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-05","filed_date":"2011-01-07","scope":"insider"},{"id":7390200,"accession":"0001209191-10-059049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-059049","line_url":"/filing/0001209191-10-059049#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":38000.0,"total_display":"38,000.00","total_whole":"38,000","shares_owned_after":177136.0,"shares_owned_after_display":"177,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-06","filed_date":"2010-12-08","scope":"insider"},{"id":7707653,"accession":"0001209191-10-053830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-053830","line_url":"/filing/0001209191-10-053830#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":4.7556,"price_display":"4.76","price_state":"stated","total_value":47556.0,"total_display":"47,556.00","total_whole":"47,556","shares_owned_after":187136.0,"shares_owned_after_display":"187,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-05","filed_date":"2010-11-08","scope":"insider"},{"id":7417285,"accession":"0001209191-10-049466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-049466","line_url":"/filing/0001209191-10-049466#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.2269,"price_display":"3.23","price_state":"stated","total_value":32269.0,"total_display":"32,269.00","total_whole":"32,269","shares_owned_after":227036.0,"shares_owned_after_display":"227,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-05","filed_date":"2010-10-05","scope":"insider"},{"id":7630486,"accession":"0001209191-10-045508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-045508","line_url":"/filing/0001209191-10-045508#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.7034,"price_display":"2.70","price_state":"stated","total_value":27034.0,"total_display":"27,034.00","total_whole":"27,034","shares_owned_after":238483.0,"shares_owned_after_display":"238,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-07","filed_date":"2010-09-08","scope":"insider"},{"id":7590683,"accession":"0001209191-10-043570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-043570","line_url":"/filing/0001209191-10-043570#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":3.0761,"price_display":"3.08","price_state":"stated","total_value":107663.5,"total_display":"107,663.50","total_whole":"107,664","shares_owned_after":248483.0,"shares_owned_after_display":"248,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-18","filed_date":"2010-08-20","scope":"insider"},{"id":7515544,"accession":"0001209191-10-041790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-041790","line_url":"/filing/0001209191-10-041790#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":32800.0,"total_display":"32,800.00","total_whole":"32,800","shares_owned_after":283483.0,"shares_owned_after_display":"283,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-05","filed_date":"2010-08-09","scope":"insider"},{"id":7515464,"accession":"0001209191-10-038006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-038006","line_url":"/filing/0001209191-10-038006#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.0203,"price_display":"3.02","price_state":"stated","total_value":30203.0,"total_display":"30,203.00","total_whole":"30,203","shares_owned_after":293483.0,"shares_owned_after_display":"293,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-07","filed_date":"2010-07-09","scope":"insider"},{"id":7430389,"accession":"0001209191-10-033120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-033120","line_url":"/filing/0001209191-10-033120#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":2.3823,"price_display":"2.38","price_state":"stated","total_value":119115.0,"total_display":"119,115.00","total_whole":"119,115","shares_owned_after":304930.0,"shares_owned_after_display":"304,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-07","filed_date":"2010-06-08","scope":"insider"},{"id":5720036,"accession":"0001209191-09-044420","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-044420","line_url":"/filing/0001209191-09-044420#line-3","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":4200.0,"total_display":"4,200.00","total_whole":"4,200","shares_owned_after":398307.0,"shares_owned_after_display":"398,307","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-15","scope":"insider"},{"id":5720034,"accession":"0001209191-09-044420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-044420","line_url":"/filing/0001209191-09-044420#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.18,"price_display":"2.18","price_state":"stated","total_value":4360.0,"total_display":"4,360.00","total_whole":"4,360","shares_owned_after":401656.0,"shares_owned_after_display":"401,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-11","filed_date":"2009-09-15","scope":"insider"},{"id":6037335,"accession":"0001209191-09-011529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-011529","line_url":"/filing/0001209191-09-011529","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (Sr. VP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Chief Medical Officer","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4263,"price_display":"0.43","price_state":"stated","total_value":4263.0,"total_display":"4,263.00","total_whole":"4,263","shares_owned_after":425738.0,"shares_owned_after_display":"425,738","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-23","filed_date":"2009-02-25","scope":"insider","n_lines":2},{"id":3944886,"accession":"0001186120-06-000034","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001186120-06-000034","line_url":"/filing/0001186120-06-000034","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001350416","owner_name":"Kaye Randall","owner_display_name":"Kaye Randall","owner_url":"/insider/0001350416","role":"Officer (VP of Medical Affairs)","role_mark":"O","role_mark_label":"Officer (VP of Medical Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Medical Affairs","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":10.0918,"price_display":"10.09","price_state":"stated","total_value":25229.5,"total_display":"25,229.50","total_whole":"25,230","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-26","filed_date":"2006-05-26","scope":"insider","n_lines":4}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001832168","name":"Longboard Pharmaceuticals, Inc.","url":"/issuer/0001832168","role":"Officer (CMO)","n_filings":3,"first_seen":"2024-08-13","last_seen":"2024-10-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001579428","name":"Axsome Therapeutics, Inc.","url":"/issuer/0001579428","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2015-12-24","last_seen":"2015-12-24"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS, INC.","url":"/issuer/0000858803","role":"Officer (Sr. VP, Chief Medical Officer)","n_filings":13,"first_seen":"2006-05-26","last_seen":"2011-09-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001350416","retrieved_at":"2026-08-23T14:49:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}